Drug Database
Back to search

Netherlands· NL-868c5e5c4328

Pipamperon Sandoz 40 mg, tabletten

A pipamperone product containing pipamperondihydrochloride, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 6 of our 19 countries.

ATC N05AD05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPipamperon Sandoz 40 mg, tablettenATCN05AD05REGISTER NO.NL-868c5e5c4328PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pipamperondihydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pipamperone is registered in 6 of 19 countries.

Countries holding a registration under ATC N05AD05 (pipamperone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 2 of them publish a price we can compare per daily dose
Search pipamperone products by name

Pipamperone · ATC N05AD05

6 / 19 countries

  • Belgiumprice
  • Denmark
  • Germany
  • Japan
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pipamperone costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pipamperone · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.64
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PIPAMPERONDIHYDROCHLORIDE
Manufacturer
Sandoz B.V.
Country
Netherlands (NL)
ATC code
N05AD05
ATC class
Pipamperone
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    29879

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

41 interactions on record for pipamperone.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pipamperone against other medicinesHow interaction checks work

Pipamperone · interactions on record

41 records

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Pipamperone in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pipamperone products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Dipiperon
  • Germany · Dipiperon, Pipamperon 1 A Pharma
  • Denmark · Dipiperon
  • France · Dipiperon
  • Greece · Dipiperon
  • Luxembourg · Dipiperon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f90e815c-95c1-4603-b0a7-d32be133d5cd
GET /v1/drugs/f90e815c-95c1-4603-b0a7-d32be133d5cd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h29879_smpc.pdf",
  "strength": null,
  "atc_label": "Pipamperone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg29879",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTODEXTRINE",
    "MAÏSZETMEEL",
    "SACCHAROSE",
    "TALK (E 553b)"
  ],
  "substances": [
    "PIPAMPERONDIHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h29879.pdf",
  "authorised_at": "2005/01/03",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "29879",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about pipamperone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console